Cyberbullying Awareness Training for Secondary School Students

June 3, 2024 updated by: Emine Ekici, Maltepe University

Investigation of the Effectiveness of Cyberbullying Awareness Training Given to Secondary School Students

The study will be conducted with the randomized controlled experimental method. The purpose of this research is to determine the cyberbullying awareness training given to 7th-grade secondary school students' awareness levels of cyberbullying. Students will be randomly assigned to groups by lottery method. After the randomization students in the intervention group will be given 'Cyberbullying Awareness Training'. The cyberbullying awareness level of all students will be determined with the 'Cyberbullying Awareness Scale' before and 3 months after the training. Students in the control group will not be educated. The cyberbullying awareness level of the students in the control group will be determined with the 'Cyberbullying Awareness Scale' when they are included in the research and 3 months later.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

122

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • İ̇stanbul
      • İstanbul, İ̇stanbul, Turkey, 34852
        • Maltepe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being between the ages of 12 and 14,
  • No auditory, visual, or mental problems that would affect communication
  • Speaking and understanding Turkish at native level

Exclusion Criteria:

  • Being younger than 12 years old and older than 14 years old,
  • Having auditory, visual, or mental problems that would affect communication
  • Not speaking and understanding Turkish at native level

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
The 'Cyberbullying Awareness Training' program will be implemented in 2 sessions in 1 day for a total of 2 hours.
Behavioral: Cyberbullying Awareness Training
The 'Cyberbullying Awareness Training' program will be implemented in 2 sessions in 1 day for a total of 2 hours. The training program will be implemented in line with the headings 'Definition of cyberbullying, Cyberbullying tools and practices, Case studies on cyberbullying, Causes of cyberbullying, Academic, social, psychological and physical effects of cyberbullying, Coping strategies with cyberbullying'.
No Intervention: Control Group
The Cyberbullying Awareness Training program will not be applied to students in the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cyberbullying Awareness Level
Time Frame: Before and 3 months after the Cyberbullying Awareness Training.
"Cyberbullying Awareness Scale" will be used to determine students' cyberbullying awareness levels. Regarding the consistency of the scale, Cronbach's alpha value was found to be 0.89. As a result of the clustering analysis, it was found appropriate to cluster the total score to be obtained from the scale as 21-61, 62-81, 82-105, and it was stated that the score range of 21-61 can be expressed as low, 62-81 as medium and 82-105 as high cyberbullying awareness. Those who will fill in the cyberbullying awareness scale mark their level of agreement with each statement in the scale between the options (1) strongly disagree and (5) strongly agree. A minimum score of 21 and a maximum score of 105 can be obtained from the scale.
Before and 3 months after the Cyberbullying Awareness Training.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Maltepe University

Investigators

  • Principal Investigator: Zeynep Erkut, PhD, Maltepe Üniversitesi Hemşirelik Yüksekokulu

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 5, 2024

Primary Completion (Actual)

January 10, 2024

Study Completion (Actual)

April 10, 2024

Study Registration Dates

First Submitted

January 2, 2024

First Submitted That Met QC Criteria

January 2, 2024

First Posted (Actual)

January 12, 2024

Study Record Updates

Last Update Posted (Estimated)

June 4, 2024

Last Update Submitted That Met QC Criteria

June 3, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023/17-14

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cyberbullying

Clinical Trials on Cyberbullying Awareness Training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe